Simultaneous Presentation of Parvovirus B19 Infection and Systemic Lupus Erythematosus in a Patient: Description and Review of the Literature
  • Paul Chabert
    Intensive Care Unit, Cayenne General Hospital, Cayenne, French Guiana
  • Hatem Kallel
    Intensive Care Unit, Cayenne General Hospital, Cayenne, French Guiana

Keywords

Parvovirus B19, systemic lupus erythematosus, acute respiratory distress syndrome, critical care

Abstract

We present the case of a 25-year-old woman without medical history, presenting with acute respiratory failure needing mechanical ventilation. Aetiologic screening showed PVB19 primary infection and concomitant SLE flare-up. We discuss the causative interactions between PVB19 and SLE in the pathogenesis of the disease. Difficulty diagnosing inaugural SLE flare-up concomitant with PVB19 infection can lead to delayed diagnosis and treatment. Inversely, overtreating a SLE-mimicking PVB19 infection with immunosuppressive agents can be highly detrimental.

VIEW THE ENTIRE ARTICLE

References

  • Ramos-Casals M, Cuadrado MJ, Alba P, Sanna G, Brito-Zerón P, Bertolaccini L, et al. Acute viral infections in patients with systemic lupus erythematosus: description of 23 cases and review of the literature. Medicine (Baltimore) 2008;87(6):311–318.
  • Cooray M, Manolakos JJ, Wright DS, Haider S, Patel A. Parvovirus infection mimicking systemic lupus erythematosus. CMAJ 2013;185(15):1342–1344.
  • Georges E, Rihova Z, Cmejla R, Decleire PY, Langen C. Parvovirus B19 induced lupus-like syndrome with nephritis. Acta Clin Belg 2016;71(6):423–425.
  • Soloninka CA, Anderson MJ, Laskin CA. Anti-DNA and antilymphocyte antibodies during acute infection with human parvovirus B19. J Rheumatol 1989;16(6):777–781.
  • Cugler T, Carvalho LM de, Facincani I, Yamamoto AY, Silva GEB, Costa RS, et al. Severe glomerulonephritis and encephalopathy associated with parvovirus B19 infection mimicking systemic lupus erythematosus. Scand J Rheumatol 2012;41(1):79–81.
  • Loizou S, Cazabon JK, Walport MJ, Tait D, So AK. Similarities of specificity and cofactor dependence in serum antiphospholipid antibodies from patients with human parvovirus B19 infection and from those with systemic lupus erythematosus. Arthritis Rheum 1997;40(1):103–108.
  • Valencia Pacheco G, Nakazawa Ueji YE, Rodríguez Dzul EA, Angulo Ramírez AV, López Villanueva RF, Quintal Ortiz IG, et al. Serological and molecular analysis of parvovirus B19 infection in Mayan women with systemic lupus erythematosus in Mexico. Colomb Med (Cali) 2017;48(3):105–112.
  • Hession MT, Au SC, Gottlieb AB. Parvovirus B19-associated systemic lupus erythematosus: clinical mimicry or autoimmune induction? J Rheumatol 2010;37(11):2430–2432.
  • Speyer I, Breedveld FC, Dijkmans BA. Human parvovirus B19 infection is not followed by inflammatory joint disease during long term follow-up. A retrospective study of 54 patients. Clin Exp Rheumatol 1998;16(5):576–578.
  • Bengtsson A. No serological indications that systemic lupus erythematosus is linked with exposure to human parvovirus B19. Ann Rheum Dis 2000;59(1):64–6.
  • Page C, François C, Goëb V, Duverlie G. Human parvovirus B19 and autoimmune diseases. Review of the literature and pathophysiological hypotheses. J Clin Virol 2015;72:69–74.
  • Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40(9):1725.
  • Chen J, Zhang H, Chen P, Lin Q, Zhu X, Zhang L, et al. Correlation between systemic lupus erythematosus and cytomegalovirus infection detected by different methods. Clin Rheumatol 2015;34(4):691–698.
  • Chen DY, Chen YM, Tzang BS, Lan JL, Hsu TC. Th17-related cytokines in systemic lupus erythematosus patients with dilated cardiomyopathies: a possible linkage to parvovirus B19 infection. PLoS One 2014;9(12):e113889.
  • Kishi S, Yamada S, Kishi F, Shibata E, Matsuura M, Nagai K, et al. Acute glomerulonephritis in an immunocompetent elderly woman after contact with a child who had been diagnosed as erythema infectiosum. Intern Med 2012;51(16):2197–2201.
  • Waldman M, Kopp JB. Parvovirus B19 and the kidney. Clin J Am Soc Nephrol 2007;2 Suppl 1:S47–S56.
  • Isa A, Lundqvist A, Lindblom A, Tolfvenstam T, Broliden K. Cytokine responses in acute and persistent human parvovirus B19 infection. Clin Exp Immunol 2007;147(3):419–425.
  • Park SJ, Kim JH, Ha TS, Shin JI. Association of parvovirus B19 infection with systemic lupus erythematosus: role of Th1 predominance. J Rheumatol 2011;38(6):1221.
  • Tokano Y, Morimoto S, Kaneko H, Amano H, Nozawa K, Takasaki Y, et al. Levels of IL-12 in the sera of patients with systemic lupus erythematosus (SLE)—relation to Th1- and Th2-derived cytokines. Clin Exp Immunol 1999;116(1):169–173.
  • Tzang BS, Lin TM, Tsai CC, Hsu JD, Yang LC, Hsu TC. Increased cardiac injury in NZB/W F1 mice received antibody against human parvovirus B19 VP1 unique region protein. Mol Immunol 2011;48(12–13):1518–1524.
  • Lunardi C, Tinazzi E, Bason C, Dolcino M, Corrocher R, Puccetti A. Human parvovirus B19 infection and autoimmunity. Autoimmun Rev 2008;8(2):116–120.
  • Thammasri K, Rauhamäki S, Wang L, Filippou A, Kivovich V, Marjomäki V, et al. Human parvovirus B19 induced apoptotic bodies contain altered self-antigens that are phagocytosed by antigen presenting cells. PLoS One 2013;8(6):e67179.
  • Meyer O. Parvovirus B19 and autoimmune diseases. Joint Bone Spine 2003;70(1):6–11.
  • Pavlovic M, Kats A, Cavallo M, Shoenfeld Y. Clinical and molecular evidence for association of SLE with parvovirus B19. Lupus 2010;19(7):783–792.

    • Views: 592
    HTML downloads: 74
    PDF downloads: 514

    Published: 2020-10-19
    Issue: 2020: Vol 7 No 12 (view)

    How to cite:
    1.
    Chabert P, Kallel H. Simultaneous Presentation of Parvovirus B19 Infection and Systemic Lupus Erythematosus in a Patient: Description and Review of the Literature. EJCRIM 2020;7 doi:10.12890/2020_001729.